Active Ingredient History

  • Now
Tranilast is an antiallergic drug. It was developed by Kissei Pharmaceuticals and was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in the 1980s.   Wikipedia

  • SMILES: COc1ccc(\C=C\C(=O)Nc2ccccc2C(=O)O)cc1OC
  • Mol. Mass: 327.34
  • ALogP: 3.05
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
2-((3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid | mk-341 | n-(3,4-dimethoxycinnamoyl)anthranilic acid | n-(3',4'-dimethoxycinnamoyl)anthranilic acid | rizaben | tranilast | tranilast hydrate | tranilast sodium | tranilast sodium salt | tranilastum


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue